Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Clear all

184 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20033
20042
20056
20064
20089
20095
20106
20116
20128
20136
20148
201510
20166
20178
20188
20199
20205
20219
202210
202310
20248
202511
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Terminated25
Recruiting21
Active, not recruiting14
Unknown status11
Not yet recruiting10
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)9
MedImmune LLC5
UCB Pharma5
Amgen4
AstraZeneca4
Bristol-Myers Squibb4
GlaxoSmithKline4
Novartis Pharmaceuticals4
Peking University People's Hospital4
Assistance Publique - Hôpitaux de Paris3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic184
Lupus Nephritis20
Autoimmune Diseases15
Arthritis, Rheumatoid9
Immune System Diseases7
Connective Tissue Diseases6
Lupus Erythematosus, Cutaneous5
Scleroderma, Systemic4
Sjogren's Syndrome4
Arthritis3

Trials

Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.

84 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.